美股的biotech真是便宜查看全文
网络异常请稍后再试2023-03-02 14:35
$G1治疗(GTHX)$
chuminhua
3小时前
来自 新版微博 weibo.com
3月1日,G1 Therapeutics 周三在其第四季度业绩中披露,其骨髓保护疗法 trilaciclib 对转移性三阴性乳腺癌 (TNBC) 患者的中期总生存期 (OS)...查看全文
牛唐2023-02-14 22:36
医药板块速评(2023.02.13)
1、大药企普遍回调,有哪些公司值得关注?
2、$G1治疗(GTHX)$ 暴跌,是否有抄底机会?
3、$蔚来(NIO)$ 、$苹果(AAPL)$ 期权大量成交,后续走势如何看?查看全文
$G1治疗(GTHX)$ 内部交易: 2022-01-05,Chief Business Officer,Avagliano Mark ,卖出,1445普通股, $10.61
$G1治疗(GTHX)$ 内部交易: 2022-01-05,Chief Medical Officer,Malik Rajesh ,卖出,1445普通股, $10.61
$G1治疗(GTHX)$ 内部交易: 2022-01-05,CFO,Moses Jennifer K. ,卖出,1445普通股, $10.61
$G1治疗(GTHX)$ 内部交易: 2022-01-05,COO,MURDOCK TERRY L ,卖出,1445普通股, $10.61
$G1治疗(GTHX)$ 内部交易: 2022-01-05,General Counsel,Hanson James S. ,卖出,1445普通股, $10.61
$G1治疗(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-000309 Size: 10 KB 网页链接
$G1治疗(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-000305 Size: 13 KB 网页链接
$G1治疗(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-000306 Size: 13 KB 网页链接
$G1治疗(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-000307 Size: 13 KB 网页链接
$G1治疗(GTHX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-22-000308 Size: 11 KB 网页链接